Draft Guidance for Industry and Food and Drug Administration Staff: Investigational New Drug Applications for Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specified Indications; Availability
Document ID: FDA-2009-D-0490-0001
Comments
Total: 6
-
Daniel Weisdorf - Comment
Posted : 01/06/2010 ID ：FDA-2009-D-0490-0003 Agency : FDA -
Jan 19,2010 11:59 PM ET
-
Dana-Farber Cancer Institute - Comment
Posted : 01/07/2010 ID ：FDA-2009-D-0490-0004 Agency : FDA -
Jan 19,2010 11:59 PM ET
-
Puget Sound Blood Center - Comment
Posted : 01/13/2010 ID ：FDA-2009-D-0490-0005 Agency : FDA -
Jan 19,2010 11:59 PM ET
-
AABB - Comment
Posted : 01/19/2010 ID ：FDA-2009-D-0490-0006 Agency : FDA -
Jan 19,2010 11:59 PM ET
-
St Louis Cord Blood Bank - Comment
Posted : 01/19/2010 ID ：FDA-2009-D-0490-0008 Agency : FDA -
Jan 19,2010 11:59 PM ET
-
StemCyte - Comment
Posted : 01/26/2010 ID ：FDA-2009-D-0490-0009 Agency : FDA -
Jan 19,2010 11:59 PM ET